LivaNova PLC Earnings
The next earnings date for LivaNova PLC has not yet been scheduled.
Analyst Estimates of LivaNova PLC Earnings
| No results. | |
What is an Earnings Date
An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.
Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.
Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.
LivaNova PLC Earnings: Historical
| 08/05/2026 | Before Market | $1.02 | 6.25% |
| 05/06/2026 | Before Market | $0.98 | 8.89% |
| 02/25/2026 | --- | $0.86 | 6.12% |
| 11/05/2025 | Before Market | $0.97 | 24.36% |
| 08/06/2025 | Before Market | $1.05 | 20.69% |
| 05/07/2025 | Before Market | $0.88 | 15.79% |
| 02/19/2025 | Before Market | $0.81 | 1.17% |
| 10/30/2024 | Before Market | $0.90 | 25.00% |
| 07/31/2024 | Before Market | $0.93 | 19.23% |
| 05/01/2024 | Before Market | $0.73 | 48.98% |
More About LivaNova PLC
LivaNova PLC, a medical technology company, designs, develops, manufactures, markets, and sells products, therapies, and services. The company operates in two segments, Cardiopulmonary and Neuromodulation. The Cardiopulmonary segment provides cardiopulmonary products, including heart-lung machines, oxygenators, autotransfusion systems, perfusion tubing systems, cannula, and other related accessories, as well as services related products. The Neuromodulation segment offers VNS Therapy System, an implantable pulse generator and connective lead that stimulates the vagus nerve, surgical equipment to assist with the implant procedure, and equipment and instruction manuals; and devices that deliver neuromodulation therapy for treating drug-resistant epilepsy and depression. This segment also includes the development and clinical testing of aura6000 system for treating obstructive sleep apnea. It serves perfusionists, neurologists, neurosurgeons, hospitals, other healthcare professionals and medical institutions, and healthcare providers. The company sells its medical devices through direct sales representatives, agents, and independent distributors in the United States, the United Kingdom, Germany, France, Italy, the Netherlands, Spain, Belgium, Poland, Sweden, Switzerland, Austria, Norway, Portugal, Finland, Denmark, and internationally. LivaNova PLC was incorporated in 2015 and is headquartered in Gloucester, the United Kingdom.
“LivaNova PLC Earnings” Can Refer to the LivaNova PLC Earnings Date
Some people say “LivaNova PLC earnings” as a shortform way to refer to the earnings date.
For example, someone might say, “I plan to hold my LivaNova PLC position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.
Owning LivaNova PLC Stock on the Earnings Date
If you own LivaNova PLC stock (LIVN) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.
A company’s earnings typically have a big impact on its stock price, which explains why the stock price for LivaNova PLC might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.
There is often a big audience of investors involved with trading LivaNova PLC shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.
These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.
Learning More LivaNova PLC Earnings
You can contact us any time if you would like to ask questions about LivaNova PLC earnings or anything else related to the stock market.